Skip to main content
Clinical Trials/CTRI/2018/11/016325
CTRI/2018/11/016325
Recruiting
未知

TWO TIER VASCULAR ACCESS SURVEILLANCE (VAS) SYSTEM:A MULTI-CENTRIC, PILOT STUDY TO IMPROVE PATENCY OF ARTERIOVENOUS FISTULA (AVF) AND ARTERIOVENOUS GRAFT (AVG)

I0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: N186- End stage renal diseaseHealth Condition 2: Z00-Z99- Factors influencing health status and contact with health services
Sponsor
I
Status
Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
I

Eligibility Criteria

Inclusion Criteria

  • 1\) Patient on dialysis \> 2 times per week with mature upper extremity AVF/ AVG in use for 1 month or more which is able to provide flow rates of \> 250 ml/min sustained for a period of 4 weeks or more.
  • 2\) Tunnel catheter with good flows for 2 weeks can be included
  • 3\) No access flow issues prior to inclusion in study (flow rates of 250ml / minutes and above can be achieved consistently for a period of 4 weeks) and patients with prior history of AV access angiography or angioplasty with functional AV access (post intervention flow rates of \> 250 ml/min sustained for a period of 4 weeks or more)
  • 4\) Adult population between ages of 18\-65 years will be included in study

Exclusion Criteria

  • 1\)Patients with documented procoagulant state.
  • 2\)Patients with more than 2 primary access failures
  • 3\)Inability to provide consent
  • 4\)Patient of acute kidney injury and patients planned for transplant in next 6 months
  • 5\)Patients of congestive heart failure (defined as EF \< 40% documented on echocardiography in the last 6 months, advanced chronic liver disease and known lower extremity peripheral vascular disease)
  • 6\)Patients needing more than standard dose of Heparin

Outcomes

Primary Outcomes

Not specified

Similar Trials